Oral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model

Author：            

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.42, Iss.2, 2013-01, pp. : 741-748

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resveratrol given intraperitoneally does not inhibit the growth of high-risk t(4;11) acute lymphoblastic leukemia cells in a NOD/SCID mouse model

By Zunino Susan J.   Storms David H.   Newman John W.   Pedersen Theresa L.   Keen Carl L.   Ducore Jonathan M.  

International Journal of Oncology, Vol. 40, Iss. 4, 2012-04 ,pp. : 1277-1284

Spandidos Publications

Access to resources Recommend Favorite

Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice

By            

International Journal of Oncology, Vol. 41, Iss. 6, 2012-01 ,pp. : 2207-2212

Spandidos Publications

Access to resources Recommend Favorite

Immune reconstitution from peripheral blood mononuclear cells inhibits lung carcinoma growth in NOD/SCID mice

By              

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1638-1644

Spandidos Publications

Access to resources Recommend Favorite

Notch signaling in T-cell acute lymphoblastic leukemia

By Weng Andrew P   Lau Arthur  

Future Oncology, Vol. 1, Iss. 4, 2005-08 ,pp. : 511-519

Future Medicine

Access to resources Recommend Favorite

Immunophenotype and increased presence of CD4+CD25+ regulatory T cells in patients with acute lymphoblastic leukemia

By          

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 421-424

Spandidos Publications

Access to resources Recommend Favorite